The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: Linking protein biosynthesis and neurodegeneration

Human Molecular Genetics

Volumn 12, Issue 12, 2003, Pages 1427-1437

  Corti, Olga ^a   Hampe, Cornelia ^a   Koutnikova, Hana ^a   Darios, Frédéric ^a   Jacquier, Sandrine ^a   Prigent, Annick ^a   Robinson, Jean Charles ^b   Pradier, Laurent ^c   Ruberg, Merle ^a   Mirande, Marc ^b   Hirsch, Etienne ^a   Rooney, Thomas ^c   Fournier, Alain ^c   Brice, Alexis ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b CNRS   (France)

^c SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID TRANSFER RNA LIGASE; PARKIN; PROTEASOME; PROTEIN SUBUNIT; SYNAPTOPHYSIN; UBIQUITIN PROTEIN LIGASE;

ANIMAL CELL; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CELL STRAIN COS7; CONTROLLED STUDY; DISEASE SEVERITY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; ENZYME SUBSTRATE; FAMILIAL DISEASE; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; LEWY BODY; MESENCEPHALON; NERVE DEGENERATION; NONHUMAN; ONSET AGE; PARKINSON DISEASE; PARKINSONISM; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS;

ADULT; AMINO ACYL-TRNA SYNTHETASES; ANIMALS; CARRIER PROTEINS; CELL DEATH; CERCOPITHECUS AETHIOPS; COS CELLS; HUMANS; INCLUSION BODIES; LEWY BODIES; MESENCEPHALON; MUTATION; NERVE DEGENERATION; NEUROBLASTOMA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PARKINSON DISEASE; SACCHAROMYCES CEREVISIAE; TWO-HYBRID SYSTEM TECHNIQUES; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES;

ANIMALIA; MAMMALIA;

EID: 10744220754     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Forno, L.S. (1996) Neuropathology of Parkinson's disease. J. Neuropathol. Exp. Neurol., 55, 259-272.
2. Brice, A. and Lansbury, P.T.J. (2002) Genetics of Parkinson's disease and biochemical studies of implicated gene products. Curr. Opin. Genet. Devel., 12, 229-306.
3. Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R. et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science, 276, 2045-2047.
4. Krüger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., Przuntek, H., Epplen, J.T., Schols, L. and Riess, O. (1998) A1a30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet., 18, 106-108.
5. Spillantini, M.G., Schmidt, M.L., Lee, V.M., Trojanowski, J.Q., Jakes, R. and Goedert, M. (1997) Alpha-synuclein in Lewy bodies. Nature, 388, 839-840.
6. Trojanowski, J.Q. and Lee, V.M. (1998) Aggregation of neurofilament and alpha-synuclein proteins in Lewy bodies: implications for the pathogenesis of Parkinson disease and Lewy body dementia. Arch. Neurol., 55, 151-152.
7. Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M.J., Jonnalagada, S., Chernova, T. et al. (1998) The ubiquitin pathway in Parkinson's disease. Nature, 395, 451-452.
8. Bonifati, V., Rizzu, P., Van Baren, M.J., Schaap, O., Breedveld, G.J., Krieger, E., Dekker, M.C., Squitieri, F., Ibanez, P., Joosse, M. et al. (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science, 299, 256-259.
9. Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y. and Shimizu, N. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature, 392, 605-608.
10. Leroy, E., Anastasopoulos, D., Konitsiotis, S., Lavedan, C. and Polymeropoulos, M.H. (1998) Deletions in the Parkin gene and genetic heterogeneity in a Greek family with early onset Parkinson's disease. Hum. Genet., 103, 424-427.
11. Abbas, N., Lücking, C.B., Ricard, S., Durr, A., Bonifati, V., De Michele, G., Bouley, S., Vaughan, J. R., Gasser, T., Marconi, R. et al. (1999) A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease. Hum. Mol. Genet., 8, 567-574.
12. Lücking, C.B., Abbas, N., Durr, A., Bonifati, V., Bonnet, A.M., de Broucker, T., De Michele, G., Wood. N.W., Agid. Y. and Brice, A. (1998) Homozygous deletions in parkin gene in European and North African families with autosomal recessive juvenile parkinsonism. The European Consortium on Genetic Susceptibility in Parkinson's Disease and the French Parkinson's Disease Genetics Study Group. Lancet, 352, 1355-1356.
13. Klein, C., Pramstaller, P.P., Kis, B., Page, C.C., Kann, M., Leung, J., Woodward, H., Castellan, C.C., Scherer, M., Vieregge, P. et al. (2000) Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: expanding the phenotype. Ann. Neurol., 48, 65-71.
14. Mori, H., Kondo, T., Yokochi, M., Matsumine, H., Nakagawa-Hattori, Y., Miyake, T., Suda, K. and Mizuno, Y. (1998) Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q. Neurology, 51, 890-892.
15. Hayashi, S., Wakabayashi, K., Ishikawa, A., Nagai, H., Saito, M., Maruyama, M., Takahashi, T., Ozawa, T., Tsuji, S. and Takahashi, H. (2000) An autopsy case of autosomal-recessive juvenile parkinsonism with a homozygous exon 4 deletion in the parkin gene. Mov. Disord., 15, 884-888.
16. van de Warrenburg, B.P., Lammens, M., Lücking, C.B., Denefle, P., Wesseling, P., Booij, J., Praamstra, P., Quinn, N., Brice, A. and Horstink, M.W. (2001) Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations. Neurology, 56, 555-557.
17. Schlossmacher, M.G., Frosch, M.P., Gai, W.P., Medina, M., Sharma, N., Forno, L., Ochiishi, T., Shimura, H., Sharon, R., Hattori, N. et al. (2002) Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies Am. J. Pathol., 160, 1655-1667.
18. Joazeiro, C.A. and Weissman, A.M. (2000) RING finger proteins: mediators of ubiquitin ligase activity. Cell, 102, 549-552.
19. Shimura, H., Hattori, N., Kubo, S., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K. et al. (2000) Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet, 25, 302-305.
20. Imai, Y., Soda, M. and Takahashi, R. (2000) Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. J. Biol. Chem., 275, 35661-35664.
21. Zhang, Y., Gao, J., Chung, K.K., Huang, H., Dawson, V.L. and Dawson, T.M. (2000) Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc. Natl Acad Sci. USA, 97, 13354-13359.
22. Imai, Y., Soda, M., Inoue, H., Hattori, N., Mizuno, Y. and Takahashi, R. (2001) An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell, 105, 891-902.
23. Chung, K.K., Zhang, Y., Lim, K.L., Tanaka, Y., Huang, H., Gao, J., Ross, C.A., Dawson, V.L. and Dawson, T.M. (2001) Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. Nat. Med., 7, 1144-1150.
24. Shimura, H., Schlossmacher, M.G., Hattori, N., Frosch, M.P., Trockenbacher, A., Schneider, R., Mizuno, Y., Kosik, K.S. and Selkoe, D.J. (2001) Ubiquitylation of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Science, 293, 263-269.
25. Staropoli, J.F., McDermott, C., Martinat, C., Schulman, B., Demireva, E. and Abeliovich, A. (2003) Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity. Neuron, 37, 735-749.
26. Quevillon, S., Robinson, J.C., Berthonneau, E., Siatecka, M. and Mirande, M. (1999) Macromolecular assemblage of aminoacyl-tRNA synthetases: identification of protein-protein interactions and characterization of a core protein. J. Mol. Biol., 285, 183-195.
27. Robinson, J.C., Kerjan, P. and Mirande, M. (2000) Macromolecular assemblage of aminoacyl-tRNA synthetases: quantitative analysis of protein-protein interactions and mechanism of complex assembly. J. Mol. Biol., 304, 983-994.
28. Nicolaides, N.C., Kinzler, K.W. and Vogelstein, B. (1995) Analysis of the 5′ region of PMS2 reveals heterogeneous transcripts and a novel overlapping gene. Genomics, 29, 329-334.
29. Meng, L., Mohan, R., Kwok, B.H., Elofsson, M., Sin, N. and Crews, C.M. (1999) Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. Proc. Natl Acad. Sci. USA, 96, 10403-10408.
30. Johnston, J.A., Ward, C.L. and Kopito, R.R. (1998) Aggresomes: a cellular response to misfolded proteins. J. Cell. Biol., 143, 1883-1898.
31. Kopito, R.R. (2000) Aggresomes, inclusion bodies and protein aggregation. Trends Cell. Biol., 10, 524-530.
32. Walters, K.J., Kleijnen, M.F., Goh, A.M., Wagner, G. and Howley, P.M. (2002) Structural studies of the interaction between ubiquitin family proteins and proteasome subunit S5a. Biochemistry, 41, 1767-1777.
33. Elsasser, S., Gali, R.R., Schwickart, M., Larsen, C.N., Leggett, D.S., Muller, B., Feng, M.T., Tubing, F., Dittmar, G.A. and Finley, D. (2002) Proteasome subunit Rpn1 binds ubiquitin-like protein domains. Nat. Cell. Biol., 4, 725-730.
34. Hyun, D.H., Lee, M., Hattori, N., Kubo, S., Mizuno, Y., Halliwell, B. and Jenner, P. (2002) Effect of wild-type or mutant Parkin on oxidative damage, nitric oxide, antioxidant defenses, and the proteasome. J. Biol. Chem., 277, 28572-28577.
35. Rankin, C.A., Joazeiro, C.A., Floor, E. and Hunter, T. (2001) E3 ubiquitin-protein ligase activity of Parkin is dependent on cooperative interaction of RING finger (TRIAD) elements. J. Biomed. Sci., 8, 421-429.
36. Imai, Y., Soda, M., Hatakeyama, S., Akagi, T., Hashikawa, T., Nakayama, K.I. and Takahashi, R. (2002) CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity. Mol. Cell, 10, 55-67.
37. Wakabayashi, K., Engelender, S., Yoshimoto, M., Tsuji, S., Ross, C.A. and Takahashi, H. (2000) Synphilin-1 is present in Lewy bodies in Parkinson's disease. Ann. Neurol., 47, 1-3.
38. Tompkins, M.M. and Hill, W.D. (1997) Contribution of somal Lewy bodies to neuronal death. Brain Res., 775, 24-29.
39. Mirande, M. (1991) Aminoacyl-tRNA synthetase family from prokaryotes and eukaryotes: structural domains and their implications. Prog. Nucl. Acid Res. Mol. Biol., 40, 95-142.
40. Kisselev, L.L. and Wolfson, A.D. (1994) Aminoacyl-tRNA synthetases from higher eucaryotes. Prog. Nucl. Acid Res. Mol. Biol., 48, 83-142.
41. Kim, J.Y., Kang, Y.S., Lee, J.W., Kim, H.J., Ahn, Y.H., Park, H., Ko, Y.G. and Kim, S. (2002) p38 is essential for the assembly and stability of macromolecular tRNA synthetase complex: implications for its physiological significance. Proc. Natl Acad. Sci. USA, 99, 7912-7916.
42. Ivanov, K.A., Moor, N.A. and Lavrik, O.I. (2000) Non-canonical functions of aminoacyl-tRNA synthetases. Biochemistry (Mosc.), 65, 888-897.
43. Ko, Y.G., Kim, E.Y., Kim, T., Park, H., Park, H.S., Choi, E.J. and Kim, S. (2001) Glutamine-dependent antiapoptotic interaction of human glutaminyl-tRNA synthetase with apoptosis signal-regulating kinase 1. J. Biol. Chem., 276, 6030-6036.
44. Wakasugi, K. and Schimmel, P. (1999) Highly differentiated motifs responsible for two cytokine activities of a split human tRNA synthetase. J. Biol. Chem., 274, 23155-13159.
45. Wakasugi, K. and Schimmel, P. (1999) Two distinct cytokines released from a human aminoacyl-tRNA synthetase. Science, 284, 147-151.
46. Kao, J., Ryan, J., Brett, G., Chen, J., Shen, H., Fan, Y.G., Godman, G., Familletti, P.C., Wang, F., Pan, Y.C. et al. (1992) Endothelial monocyte-activating polypeptide II. A novel tumor-derived polypeptide that activates host-response mechanisms. J. Biol. Chem., 267, 20239-20247.
47. Quevillon, S., Agou, F., Robinson, J.C. and Mirande, M. (1997) The p43 component of the mammalian multi-synthetase complex is likely to be the precursor of the endothelial monocyte-activating polypeptide II cytokine. J. Biol. Chem., 272, 32573-32579.
48. Park, S.G., Jung, K.H., Lee, J.S., Jo, Y.J., Motegi, H., Kim, S. and Shiba, K. (1999) Precursor of pro-apoptotic cytokine modulates aminoacylation activity of tRNA synthetase. J. Biol. Chem., 274, 16673-16676.
49. Shalak, V., Kaminska, M., Mitnacht-Kraus, R., Vandenabeele, P., Clauss, M. and Mirande, M. (2001) The EMAPII cytokine is released from the mammalian multisynthetase complex after cleavage of its p43/proEMAPII component. J. Biol. Chem., 276, 23769-23776.
50. Ko, Y.G., Park, H., Kim, T., Lee, J.W., Park, S.G., Seol, W., Kim, J.E., Lee, W.H., Kim, S.H., Park, J.E. and Kim, S. (2001) A cofactor of tRNA synthetase, p43, is secreted to up-regulate proinflammatory genes. J. Biol. Chem., 276, 23028-23033.
51. Brabeck, C., Michetti, F., Geloso, M.C., Corvino, V., Goezalan, F., Meyermann, R. and Schluesener, H.J. (2002) Expression of EMAP-II by activated monocytes/microglial cells in different regions of the rat hippocampus after trimethyltin-induced brain damage. Exp. Neurol., 177, 341-346.
52. Popenko, V.I., Ivanova, J.L., Cherny, N.E., Filonenko, V., Beresten, S.F., Wolfson, A.D. and Kisselev, L.L. (1994) Compartmentalization of certain components of the protein synthesis apparatus in mammalian cells. Eur. J. Cell. Biol., 65, 60-69.
53. Hovland, R., Hesketh, J.E. and Pryme, I.F. (1996) The compartmentalization of protein synthesis: importance of cytoskeleton and role in mRNA targeting. Biochem. Cell. Biol., 28, 1089-1105.
54. McNaught, K.S. and Jenner, P. (2001) Proteasomal function is impaired in substantia nigra in Parkinson's disease. Neurosci. Lett., 297, 191-194.
55. McNaught, K.S., Belizaire, R., Jenner, P., Olanow, C.W., Isacson, O. (2002) Selective loss of 20S proteasome alpha-subunits in the substantia nigra pars compacta in Parkinson's disease. Neurosci. Lett., 326, 155-158.
56. Chung, K.K., Dawson, V.L. and Dawson, T.M. (2001) The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders. Trends Neurosci., 24, S7-S14.
57. Gu, W.J., Abbas, N., Lagunes, M.Z., Parent, A., Pradier, L., Bohme, G.A., Agid, Y., Hirsch, E.C., Raisman-Vozari, R. and Brice, A. (2000) Cloning of rat Parkin cDNA and distribution of parkin in rat brain. J. Neurochem., 74, 1773-1776.
58. Zarate-Lagunes, M., Gu, W.J., Blanchard, V., Francois, C., Muriel, M.P., Mouatt-Prigent, A., Bonici, B., Parent, A., Hartmann, A., Yelnik, J. et al. (2001) Parkin immunoreactivity in the brain of human and non-human primates: an immunohistochemical analysis in normal conditions and in Parkinsonian syndromes. J. Comp. Neurol., 432, 184-196.
59. Hunot, S., Dugas, N., Faucheux, B., Hartmann, A., Tardieu, M., Debre, P., Agid, Y., Dugas, B. and Hirsch, E.C. (1999) FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells. J. Neurosci., 19, 3440-3447.
60. Lebre, A.S., Jamot, L., Takahashi, J., Spassky, N., Leprince, C., Ravise, N., Zander, C., Fujigasaki, H., Kussel-Andermann, P., Duyckaerts, C. et al. (2001) Ataxin-7 interacts with a Cbl-associated protein that it recruits into neuronal intranuclear inclusions. Hum. Mol. Genet., 10, 201-213.